Ron HN van Schaik

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i> and Tamoxifen Therapy

Matthew P. Goetz, Katrin Sangkuhl, Henk‐Jan Guchelaar et al. · Clinical Pharmacology & Therapeutics · 2018 · 311 citations · Full text

CYP3A5 Variant Allele Frequencies in Dutch Caucasians

Ron HN van Schaik, Ilse P. van der Heiden, John N. van den Anker et al. · Clinical Chemistry · 2002 · 302 citations · Full text

The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients

Marzia Del Re, Elisa Biasco, Stefania Crucitta et al. · European Urology · 2016 · 279 citations

Urology, Engineering, Cancer Genomics +7

A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients

Laure Elens, Rachida Bouamar, Dennis A. Hesselink et al. · Clinical Chemistry · 2011 · 240 citations · Full text

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics

Clint Mizzi, Eleni Dalabira, Judit Kumuthini et al. · PLoS ONE · 2016 · 153 citations · Full text

Genetic Epidemiology, Genome-wide Association Study, Biomarker (Medicine) +18